INVEGA SUSTENNA
NDC 50458-562 · Janssen Pharmaceuticals, Inc.
Packages
50458-562-01 — 1 SYRINGE in 1 KIT (50458-562-01) / .75 mL in 1 SYRINGE
Billed under HCPCS
J2426 — Injection, paliperidone palmitate extended release (invega sustenna), 1 mg Medicare Part B payment limit (ASP + 6%): $15.43
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50458-560 — paliperidone palmitate, 50458-561 — paliperidone palmitate, 50458-563 — paliperidone palmitate, 50458-564 — paliperidone palmitate, 50458-606 — paliperidone palmitate, 50458-607 — paliperidone palmitate, 50458-608 — paliperidone palmitate, 50458-609 — paliperidone palmitate, 50458-611 — paliperidone palmitate, 50458-612 — paliperidone palmitate, 72526-105 — paliperidone palmitate, 72526-106 — paliperidone palmitate, 72526-107 — paliperidone palmitate, 72526-108 — paliperidone palmitate, 72526-109 — paliperidone palmitate, 72526-110 — paliperidone palmitate